Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 53 results.
User Information
Export Records
  1. 1.   Quantitation of Active Pharmaceutical Ingredients in Polymeric Drug Products Using Elemental Analysis
  2. Xu,Jie; Hu, Yingwen; Clogston,Jeffrey
  3. Methods in Molecular Biology (Clifton, N.J.). 2024 2789: 35-43.
  1. 2.   Plasma Stability and Plasma Metabolite Concentration-Time Profiles of Oligo(Lactic Acid)8-Paclitaxel Prodrug Loaded Polymeric Micelles
  2. Repp, Lauren; Skoczen,Sarah; Rasoulianboroujeni, Morteza; Stern,Steve; Kwon, Glen S
  3. The AAPS Journal. 2023, Apr 11; 25(3): 39.
  1. 3.   Application of a Scavenger Receptor A1-Targeted Polymeric Prodrug Platform for Lymphatic Drug Delivery in HIV
  2. Stevens,David; Adiseshaiah, Pavan; Dasa,Siva Sai Krishna; Potter,Tim; Skoczen,Sarah; Snapp,Kelsie; Cedrone,Edward; Patel,Nimit; Busman-Sahay, Kathleen; Rosen, Elias P.; Sykes, Craig; Cottrell, Mackenzie; Dobrovolskaia,Marina; Estes, Jacob D.; Kashuba, Angela D. M.; Stern,Steve
  3. MOLECULAR PHARMACEUTICS. 2020, OCT 5; 17(10): 3794-3812.
  1. 4.   Total drug quantification in prodrugs using an automated elemental analyzer
  2. Hu,Yingwen; Stevens,David; Man, Sonny; Crist,Rachael; Clogston,Jeffrey
  3. Drug delivery and translational research. 2019, Dec; 9(6): 1057-1066.
  1. 5.   Bioreductively activatable prodrug conjugates of phenstatin designed to target tumor hypoxia
  2. Winn, Blake A; Shi, Zhe; Carlson, Graham J; Wang, Yifan; Nguyen, Benson L; Kelly, Evan M; Ross, R David; Hamel, Ernest; Chaplin, David J; Trawick, Mary L; Pinney, Kevin G
  3. Bioorganic & medicinal chemistry letters. 2017, Feb 01; 27(3): 636-641.
  1. 6.   Design, synthesis, and biological evaluation of water-soluble amino acid prodrug conjugates derived from combretastatin, dihydronaphthalene, and benzosuberene-based parent vascular disrupting agents
  2. Devkota, L.; Lin, C. M.; Strecker, T. E.; Wang, Y.; Tidmore, J. K.; Chen, Z.; Guddneppanavar, R.; Jelinek, C. J.; Lopez, R.; Liu, L.; Hamel, E.; Mason, R. P.; Chaplin, D. J.; Trawick, M. L.; Pinney, K. G.
  3. Bioorganic & Medicinal Chemistry. 2016, 1-Mar; 24(5): 938-56.
  1. 7.   Growth-inhibitory and chemosensitizing effects of the glutathione-S-transferase-p-activated nitric oxide donor PABA/NO in malignant gliomas
  2. Kogias, E.; Osterberg, N.; Baumer, B.; Psarras, N.; Koentges, C.; Papazoglou, A.; Saavedra, J. E.; Keefer, L. K.; Weyerbrock, A.
  3. International Journal of Cancer. 2012, Mar; 130(5): 1184-1194.
  1. 8.   Diazeniumdiolated carbamates: A novel class of nitric oxide donors
  2. Nandurdikar, R. S.; Maciag, A. E.; Cao, Z.; Keefer, L. K.; Saavedra, J. E.
  3. Bioorganic & Medicinal Chemistry. 2012, Mar; 20(6): 2025-2029.
  1. 9.   Antineoplastic Agents. 548. Synthesis of lodo- and Diiodocombstatin Phosphate Prodrugs
  2. Pettit, G. R.; Rosenberg, H. J.; Dixon, R.; Knight, J. C.; Hamel, E.; Chapuis, J. C.; Pettit, R. K.; Hogan, F.; Sumner, B.; Ain, K. B.; Trickey-Platt, B.
  3. Journal of Natural Products. 2012, Mar; 75(3): 385-393.
  1. 10.   Nitric oxide donor, V-PROLI/NO, provides protection against arsenical induced toxicity in rat liver cells: Requirement for Cyp1a1
  2. Qu, W.; Cheng, L. D.; Dill, A. L.; Saavedra, J. E.; Hong, S. Y.; Keefer, L. K.; Waalkes, M. P.
  3. Chemico-Biological Interactions. 2011, Aug; 193(1): 88-96.
  1. 11.   Regioselective Synthesis of Water-Soluble Monophosphate Derivatives of Combretastatin A-1
  2. Tanpure, R. P.; Nguyen, B. L.; Strecker, T. E.; Aguirre, S.; Sharma, S.; Chaplin, D. J.; Siim, B. G.; Hamel, E.; Lippert, J. W.; Pettit, G. R.; Trawick, M. L.; Pinney, K. G.
  3. Journal of Natural Products. 2011, Jul; 74(7): 1568-1574.
  1. 12.   Novel protection-deprotection strategies in diazeniumdiolate chemistry: synthesis of V-IPA/NO
  2. Nandurdikar, R. S.; Keefer, L. K.; Saavedra, J. E.
  3. Chemical Communications. 2011, Jun 21; 47(23): 6710-6712.
  1. 13.   The Nitric Oxide Prodrug V-PROLI/NO Inhibits Cellular Uptake of Proline
  2. Hong, S. Y.; Borchert, G. L.; Maciag, A. E.; Nandurdikar, R. S.; Saavedra, J. E.; Keefer, L. K.; Phang, J. M.; Chakrapani, H.
  3. Acs Medicinal Chemistry Letters. 2010, Nov; 1(8): 386-389.
  1. 14.   Click Reaction in Conjunction with Diazeniumdiolate Chemistry: Developing High-Load Nitric Oxide Donors
  2. Oladeinde, O. A.; Hong, S. Y.; Holland, R. J.; Maciag, A. E.; Keefer, L. K.; Saavedra, J. E.; N, urdikar
  3. Organic Letters. 2010, Oct; 12(19): 4256-4259.
  1. 15.   Nitrogen-bound diazeniumdiolated amidines
  2. Biswas, D.; Deschamps, J. R.; Keefer, L. K.; Hrabie, J. A.
  3. Chemical Communications. 2010, Aug 21; 46(31): 5799-5801.
  1. 16.   Soft alkyl ether prodrugs of a model phenolic drug: the effect of incorporation of ethyleneoxy groups on transdermal delivery
  2. Thomas, J. D.; Majumdar, S.; Sloan, K. B.
  3. Molecules (Basel, Switzerland). 2009 14(10): 4231-45.
  1. 17.   An improved synthesis of V-PROLI/NO, a cytochrome P450-activated nitric oxide prodrug
  2. Hong, S. Y.; Nandurdikar, R. S.; Keefer, L. K.; Saavedra, J. E.; Chakrapani, H.
  3. Tetrahedron Letters. 2009 50(31): 4545-4548.
  1. 18.   Synthesis and evaluation of piperazine and homopiperazine analogues of JS-K, an anti-cancer lead compound
  2. Nandurdikar, R. S.; Maciag, A. E.; Citro, M. L.; Shami, P. J.; Keefer, L. K.; Saavedra, J. E.; Chakrapani, H.
  3. Bioorganic & Medicinal Chemistry Letters. 2009 19(10): 2760-2762.
  1. 19.   E-Combretastatin and E-resveratrol structural modifications: Antimicrobial and cancer cell growth inhibitory beta-E-nitrostyrenes
  2. Pettit, R. K.; Pettit, G. R.; Hamel, E.; Hogan, F.; Moser, B. R.; Wolf, S.; Pon, S.; Chapuis, J. C.; Schmidt, J. M.
  3. Bioorganic & Medicinal Chemistry. 2009 17(18): 6606-6612.
  1. 20.   Aryl Bis(diazeniumdiolates): Potent Inducers of S-Glutathionylation of Cellular Proteins and Their in Vitro Antiproliferative Activities
  2. Andrei, D.; Maciag, A. E.; Chakrapani, H.; Citro, M. L.; Keefer, L. K.; Saavedra, J. E.
  3. Journal of Medicinal Chemistry. 2008 51(24): 7944-7952.
  1. 21.   Synthesis, mechanistic studies, and anti-proliferative activity of glutathione/glutathione S-transferase-activated nitric oxide prodrugs
  2. Chakrapani, H.; Kalathur, R. C.; Maciag, A. E.; Citro, M. L.; Ji, X. H.; Keefer, L. K.; Saavedra, J. E.
  3. Bioorganic & Medicinal Chemistry. 2008 16(22): 9764-9771.
  1. 22.   Cell-Permeable Esters of Diazeniumdiolate-Based Nitric Oxide Prodrugs
  2. Chakrapani, H.; Maciag, A. E.; Citro, M. L.; Keefer, L. K.; Saavedra, J. E.
  3. Organic Letters. 2008 10(22): 5155-5158.
  1. 23.   Griffithsin, a potent HIV entry inhibitor, is an excellent candidate for anti-HIV microbicide
  2. Emau, P.; Tian, B.; O'Keefa, B. R.; Mori, T.; McMahon, J. B.; Palmer, K. E.; Jiang, Y.; Bekele, G.; Tsai, C. C.
  3. Journal of Medical Primatology. 2007, Aug; 36(4-5): 244-253.
  1. 24.   Metabolism of a liver-selective nitric oxide-releasing agent, V-PYRRO/NO, by human microsomal cytochromes P450
  2. Inami, K.; Nims, R. W.; Srinivasan, A.; Citro, M. L.; Saavedra, J. E.; Cederbaum, A. I.; Keefer, L. K.
  3. Nitric Oxide-Biology and Chemistry. 2006, Jun; 14(4): 309-315.
  1. 25.   Benzoylphenylurea sulfur analogues with potent antitumor activity
  2. Hallur, G.; Jimeno, A.; Dalrymple, S.; Zhu, T.; Jung, M. K.; Hidaleo, M.; Isaacs, J. T.; Sukumar, S.; Hamel, E.; Khan, S. R.
  3. Journal of Medicinal Chemistry. 2006, Apr; 49(7): 2357-2360.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel